[Translation] Phase III study of safety and efficacy of PA21 chewable tablet and sevelamer carbonate in the treatment of hyperphosphatemia in Chinese CKD patients
该临床研究的目的是通过与碳酸司维拉姆比较,评估PA21在中国成年维持性透析的CKD受试者中降低血清磷方面的安全性和有效性
[Translation] The purpose of this clinical study was to evaluate the safety and efficacy of PA21 in reducing serum phosphorus in Chinese adult CKD subjects on maintenance dialysis by comparison with sevelamer carbonate